Gallbladder and biliary disease: GLP-1based therapies have been associated with an increased risk of gallbladder problems, including gallstones and cholecystitis
HPA Axis Dysfunction The body contains an extensive amount of regulatory systems to keep itself healthy
These are not compounded versions but are rigorously tested for consistent effectiveness and safety
Find Out If Wegovy is Clinically Suitable Clinician-led medical assessment Personalised dosing and nutrition support Ongoing clinical monitoring throughout treatment How Wegovy Works to Reduce Appetite Wegovy (semaglutide) is a GLP-1 receptor agonist, which means it works by mimicking a naturally occurring hormone in the body
Patients who have struggled with obesity their entire lives are finally losing weight
It includes 1-Db Overdrive, which is designed to deliver stimulant-driven energy, suppresses appetite, and enhances focus, and Thyro-Drive, which is formulated to support healthy thyroid and metabolic function for more efficient calorie burning